Stephen Chanock

Chief, Laboratory of Translational Genomics, National Cancer Institute

Dr. Chanock received his M.D. from Harvard Medical School in 1983 and completed clinical training in pediatrics, pediatric infectious diseases, and pediatric hematology/oncology and research training in molecular genetics at Boston Children’s Hospital and the Dana-Farber Cancer Institute, Boston. Afterwards, he joined the National Cancer Institute, initially in the Pediatric Oncology Branch where he became a Senior Investigator. Several years ago he transitioned to the Division of Cancer Epidemiology and Genetics, where he has lead a highly productive program mapping cancer susceptibility genes. In 2001, he became director of the NCI Core Genotyping Facility and in 2005 he became co-leader of the Cancer Genetic Markers of Susceptibility (CGEMS) project. In 2007, he became the Chief of the newly formed Laboratory of Translational Genomics. Dr. Chanock has published nearly 600 peer review papers and recently received the prestigious Moyent and Rothschild Sabbatical Award at the Institute Curie in Paris, France.

Become a TIGER 21 Member

Success is where we begin.
Submit Inquiry

Become a TIGER 21 Chair

TIGER 21 Chairs have achieved the kind of success most people can only imagine. Now is your opportunity to do even more – for you and for others.
Submit Inquiry